| Log in

Exclusive: Quadria invests in Rakesh Jhunjhunwala-backed Concord Biotech

02 May, 2016

India and Southeast Asia-focused healthcare private equity firm Quadria Capital has picked up a stake in Ahmedabad-based drugmaker Concord Biotech Ltd, marking its third deal in In ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Quadria Capital backs Strand Life Sciences

Quadria Capital backs Strand Life Sciences

Joseph Rai 4 months ago
Strand Life Sciences Pvt. Ltd, which focuses on clinical genomics and...
Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

Jyotindra Dubey 9 months ago
Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20...
Quadria Capital-led consortium buys majority stake in multispecialty hospital chain Medica Synergie

Quadria Capital-led consortium buys majority stake in multispecialty hospital chain Medica Synergie

Lohit Jagwani 4 years ago
Asian healthcare sector-focused private equity firm Quadria Capital, along with...
No Comments

Exclusive: Quadria invests in Rakesh Jhunjhunwala-backed Concord Biotech

Powered by WordPress.com VIP